Immune Resilience & Post-Viral Stack
Thymosin α1 and Thymalin identity. Zadaxin is not a US NDA. This is not a viral-pathogenesis or thymic-regeneration treatment page.
Duration
4-8 weeks (or acute during infection)
First reports
1-2 weeks
SKUs on this map
5
1Overview
Zadaxin (thymalfasin) has an international hepatitis file. US research-chem TA-1 is not that product. Thymalin data is mostly Khavinson. This page does not truncate flu, treat Long-COVID, or regenerate a thymus. LL-37 is not a Lyme protocol.
Ideal Candidates
Contraindications
2The Science
The thymus involutes with age. That is biology. Thymosin α1 (Zadaxin) and Thymalin are different products with different regulatory stories. LL-37 is a membrane-active AMP. KPV is an α-MSH fragment. None of these is a substitute for indicated antimicrobials or vaccines.
3Clinical Evidence
Key Findings
Thymosin Alpha-1 (Zadaxin) is FDA-designated orphan drug for hepatitis B treatment, approved in 35+ countries worldwide
SciClone Pharmaceuticals, regulatory data
TA-1 significantly enhances CD4+, CD8+ T-cell, dendritic cell, and NK cell responses in immunocompromised patients
Multiple hepatitis/HIV clinical trials
Thymalin treatment in elderly cohorts associated with improved T-cell subset ratios and reduced infection rates
Khavinson, St. Petersburg Institute
TA-1 used as adjunctive therapy in viral hepatitis C showing improved viral clearance when combined with interferon
Phase 3 clinical data
Thymalin showed mortality reduction in elderly populations treated with 10-day courses bi-annually over 6+ years
Khavinson bioregulator studies
Study Limitations
- ⚠Zadaxin (TA-1) is approved internationally but not FDA-approved for general immune enhancement in the US
- ⚠Thymalin data primarily from Khavinson group; independent replication limited
- ⚠Optimal cycling protocols (frequency, duration) not established in rigorous RCTs
- ⚠Use in active autoimmune disease requires careful risk-benefit assessment (may exacerbate)
- ⚠Quality varies significantly between compounded TA-1 products and pharmaceutical-grade Zadaxin
4The Peptide Stack
Thymosin Alpha-1
View Profile →Thymalfasin (Zadaxin) is an orphan-designated product with an international hepatitis story. Gray-market TA-1 is not that label.
Thymalin
View Profile →Khavinson bioregulator peptide that penetrates the thymus directly, upregulating gene expression to reverse thymic involution and restore baseline immune capacity.
Mechanism: Low-molecular-weight peptide acting directly on thymic tissue to restore functional T-cell maturation. Works through transcriptomic signaling to reverse age-related thymic shrinkage.
LL-37
View Profile →Endogenous antimicrobial peptide (cathelicidin) acting as the body's first line of defense against bacterial, viral, and fungal pathogens, while recruiting immune cells to infection sites.
Mechanism: Punctures bacterial cell membranes and binds to LPS to prevent endotoxic shock, while simultaneously agonizing formyl peptide receptors to enhance immune signaling.
Ultra-potent natural tripeptide that regulates mast cells and drives down systemic inflammation without suppressing the immune system's ability to fight pathogens.
Mechanism: Penetrates cells directly to inhibit NF-κB (the master switch for inflammation), shutting down hyper-inflammatory cytokine storms often seen in severe microbial infections.
Thymopentin
View Profile →TP-5 (Arg-Lys-Asp-Val-Tyr) thymopoietin fragment. Historical immune research — not thymosin alpha-1 and not Thymalin.
5Protocol Tiers
Acute Viral Defense
How the SKU shows up next to early viral folklore. This is not a flu-treatment protocol.
The Thymic Master-Reset
Khavinson-style short thymic-extract course. Observational, not a US thymic-regeneration NDA.
Heavy Antimicrobial Sweep
LL-37 identity as a cathelicidin AMP. Not a biofilm, Lyme, SIBO, or Candida protocol on this site.
6Lifestyle Integration
Lifestyle notes that travel with these SKUs. Not a prescription and not required for the math to be valid.
Training
Moderate cardiovascular exercise promotes lymphatic drainage (crucial for clearing pathogen debris). Conversely, extreme endurance training during acute illness suppresses the nervous system and prolongs sickness.
Nutrition
A heavily nutrient-dense diet focusing on Vitamin D3 (mandatory for immune signaling), Zinc, and Vitamin C. Avoid ultra-processed sugars, which paralyze white blood cell phagocytosis for hours post-consumption.
Sleep
Sleep still matters for recovery. It is not an immune-peptide activation switch, and missing a night does not "destroy" a research-chem course.
Stress Management
Psychological stress skyrockets cortisol. High cortisol literally induces apoptosis (death) in lymphocytes (immune cells). Active stress mitigation is vital.
7Timeline & Expectations
Days 1-5 (Acute)
Weeks 2-4 (Chronic/Reset)
8Monitoring & Safety
Key Metrics to Track
Troubleshooting
Mild localized skin redness at the injection site
- Normal peptide immune response (TA-1 and Thymalin are literally generating a rapid immune cascade)
- Totally normal. Rotate injection sites. Do not inject into existing bruised tissue.
9Further Reading
Dive deeper into the individual peptides and methodologies behind this protocol.
Thymosin Alpha 1: The Immune Peptide - From Category 2 Ban to Category 1 Comeback
Thymosin Alpha 1 has 11,000+ human clinical trial subjects and is approved in 35+ countries. Its FDA Category 2 ban and potential 2026 reinstatement make it the most important immune peptide story of the decade.
Read article →Khavinson bioregulators: published map, not a paid course dump
Professor Khavinson's short peptide bioregulators - Epitalon, Thymalin, Vilon, Cortexin - mechanisms, protocols, and evidence review.
Read article →Peptide Side Effects by Category: What to Expect & When to Stop
Category-by-category breakdown of peptide side effects - GLP-1, GH secretagogues, recovery, cognitive, and longevity peptides. Includes monitoring protocols and red flags.
Read article →